US0311621009 - AMGN - 867900 (XNAS)
AMGEN INC Aktie
320,56 USD
Aktuelle Kurse von AMGEN INC
Börse | Ticker | Währung | Letzter Umsatz | Kurs | Tagesveränderung | Tagesveränderung % |
---|---|---|---|---|---|---|
![]() NASDAQ |
AMGN
|
USD
|
06.09.2024 23:03
|
320,56 USD
| 324,36 USD | -1,17 % |
![]() XETRA |
AMG.DE
|
EUR
|
06.09.2024 17:35
|
289,45 EUR
| 291,35 EUR | -0,65 % |
Performance
Tag | Woche | Monat | 3 Monate | 6 Monate | 1 Jahr | 5 Jahre |
---|---|---|---|---|---|---|
0,00 % | -3,98 % | 2,58 % | 5,09 % | 16,06 % | 23,82 % | 54,32 % |
Firmenprofil zu AMGEN INC Aktie
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. It has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and research and development collaboration with Neumora Therapeutics, Inc. and Plexium, Inc. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.
Investierte Fonds
Folgende Fonds haben in AMGEN INC investiert:
Fonds | Vol. in Mio 2.953,80 | Anteil (%) 6,93 % |
Fonds | Vol. in Mio 11.287,43 | Anteil (%) 4,18 % |
Fonds | Vol. in Mio 5.880,99 | Anteil (%) 1,71 % |
Fonds | Vol. in Mio 6.933,02 | Anteil (%) 1,71 % |
Fonds | Vol. in Mio 6.068,54 | Anteil (%) 1,66 % |
Unternehmensdaten zur AMGEN INC Aktie
Name AMGEN INC
Firma Amgen Inc.
Symbol AMGN
Website https://www.amgen.com
Heimatbörse
NASDAQ
![XNAS](https://cdn.gospatz.com/mic/XNAS.png)
WKN 867900
ISIN US0311621009
Wertpapierart Aktie
Sektor Healthcare
Branche Drug Manufacturers - General
CEO Mr. Robert A. Bradway
Marktkapitalisierung 179 Mrd.
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 26,7 T
Adresse One Amgen Center Drive, 91320-1799 Thousand Oaks
IPO Datum 1983-06-17
Dividenden von AMGEN INC
Ex-Datum | Dividende pro Aktie |
---|---|
16.08.2024 | 2,25 USD |
16.05.2024 | 2,25 USD |
15.02.2024 | 2,25 USD |
16.11.2023 | 2,13 USD |
17.08.2023 | 2,13 USD |
17.05.2023 | 2,13 USD |
14.02.2023 | 2,13 USD |
16.11.2022 | 1,94 USD |
17.08.2022 | 1,94 USD |
16.05.2022 | 1,94 USD |
Aktien-Splits
Datum | Split |
---|---|
22.11.1999 | 2:1 |
01.03.1999 | 2:1 |
16.08.1995 | 2:1 |
11.09.1991 | 3:1 |
13.08.1990 | 2:1 |
Ticker Symbole
Name | Symbol |
---|---|
Frankfurt | AMG.F |
NASDAQ | AMGN |
XETRA | AMG.DE |
Weitere Aktien
Investoren die AMGEN INC halten haben auch folgende Aktien im Depot:
Die Finanzplattform goSPATZ trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
All rights reserved © LCP GmbH 2024